At a glance
ClinicalIndex Comparison RecordN/ACompleted· 169 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
In Brief
An observational study for MRSA Infections. Completed, enrolled 169 participants across 1 site.
Detailed Summary
This study prospectively selects the patients to examine the effectiveness of the investigators' current standard of prophylaxis prior to vascular surgery and to compare the effectiveness of vancomycin and daptomycin plus cefazolin in reducing infections in vascular surgical patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMRSA Infections
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
Primary CompletionJun 2009
First PostedAug 2009
Study CompletionAug 2010
TodayJul 2026
First PostedAug 28, 2009
Enrollment StartAug 1, 2007
Primary CompletionJun 1, 2009
Study CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.8 years ago